EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect

M Gärde iD, G J Matheson, K Varnäs, P Svenningsson, E Hedman-Lagerlöf, J Lundberg, L Farde, M Tiger

International Journal of Neuropsychopharmacology · 01.05.2024 · 27 (5)

DOI: 10.1093/ijnp/pyae021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 02.05.2024. Verfasst von M Gärde und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stoc…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Escitalopram, Positron-Emission Tomography, Receptor, Serotonin, 5-HT1B. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Major depressive disorder (MDD) is commonly treated with selective serotonin reuptake inhibitors (SSRIs). SSRIs inhibit the serotonin transporter (5-HTT), but the downstream antidepressant mechanism of action of these drugs is poorly understood. The serotonin 1B (5-HT1B) receptor is functionally linked to 5-HTT and 5-HT1B receptor binding and 5-HT1B receptor mRNA is reduced in the raphe nuclei after SSRI administration in primates and rodents, respectively. The effect of SSRI treatment on 5-HT1B receptor binding in patients with MDD has not been examined previously. This positron emission tomography (PET) study aimed to quantify brain 5-HT1B receptor binding changes in vivo after SSRI treatment for MDD in relation to treatment effect.

Methods

Eight unmedicated patients with moderate to severe MDD underwent PET with the 5-HT1B receptor radioligand [11C]AZ10419369 before and after 3 to 4 weeks of treatment with the SSRI escitalopram 10 mg daily. Depression severity was assessed at time of PET and after 6 to 7 weeks of treatment with the Montgomery-Åsberg Depression Rating Scale.

Results

We observed a significant reduction in [11C]AZ10419369 binding in a dorsal brainstem (DBS) region containing the median and dorsal raphe nuclei after escitalopram treatment (P = .036). Change in DBS [11C]AZ10419369 binding correlated with Montgomery-Åsberg Depression Rating Scale reduction after 3-4 (r = 0.78, P = .021) and 6-7 (r = 0.94, P < .001) weeks’ treatment.

Conclusions

Our findings align with the previously reported reduction of 5-HT1B receptor binding in the raphe nuclei after SSRI administration and support future studies testing change in DBS 5-HT1B receptor binding as an SSRI treatment response marker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderEscitalopramPositron-Emission TomographyReceptor, Serotonin, 5-HT1BSelective Serotonin Reuptake InhibitorsAdultFemaleHumansMaleMiddle AgedYoung AdultBenzopyransBrainCitalopramMorpholinesPiperazinesProtein BindingTreatment Outcome

Stichwörter der Autor:innen

5-HT1B receptorPositron emission tomographySSRImajor depressive disorder

Substanzen

5-methyl-8-(4-methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid (4-morpholin-4-yl-phenyl)amideBenzopyransCitalopramEscitalopramMorpholinesPiperazinesReceptor, Serotonin, 5-HT1BSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
  • Department of Psychiatry, Columbia University, New York, USA.
  • Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: M Gärde

Zitieren

APA

Gärde, M., Matheson, G. J., Varnäs, K., Svenningsson, P., Hedman-Lagerlöf, E., Lundberg, J., Farde, L., & Tiger, M. (2024). Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect. International Journal of Neuropsychopharmacology, 27(5). https://doi.org/10.1093/ijnp/pyae021

Vancouver

Gärde M, Matheson GJ, Varnäs K, Svenningsson P, Hedman-Lagerlöf E, Lundberg J, et al. Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect. International Journal of Neuropsychopharmacology. 2024;27(5). doi:10.1093/ijnp/pyae021

BibTeX
@article{Grde2024,
  author = {Gärde, M and Matheson, G J and Varnäs, K and Svenningsson, P and Hedman-Lagerlöf, E and Lundberg, J and Farde, L and Tiger, M},
  title = {Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2024},
  volume = {27},
  number = {5},
  doi = {10.1093/ijnp/pyae021}
}
Kostenlos starten →